共 50 条
Collaborative Referral Model for Hepatitis C Screening and Treatment in a Remote Mountainous Region of Taiwan during the COVID-19 Pandemic
被引:0
|作者:
Tai, Chi-Ming
[1
,2
]
Bair, Ming-Jong
[3
,4
]
Chen, Tzu-Haw
[1
]
Tseng, Cheng-Hao
[5
,6
]
Chen, Chih-Cheng
[5
,6
]
Lam, Hung
[7
]
Yu, Ming-Lung
[8
,9
,10
,11
]
机构:
[1] I Shou Univ, E Da Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Kaohsiung 824, Taiwan
[2] I Shou Univ, Coll Med, Sch Med Int Students, Kaohsiung 824, Taiwan
[3] Taitung Mackay Mem Hosp, Dept Internal Med, Div Gastroenterol, Taitung 950408, Taiwan
[4] Mackay Med Coll, Dept Med, New Taipei 252, Taiwan
[5] I Shou Univ, E Da Canc Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Kaohsiung 824, Taiwan
[6] I Shou Univ, Coll Med, Sch Med, Kaohsiung 824, Taiwan
[7] Liouguei Dist Publ Hlth Ctr, Kaohsiung 844, Taiwan
[8] Natl Sun Yat sen Univ, Coll Med, Sch Med, Kaohsiung 804, Taiwan
[9] Natl Sun Yat sen Univ, Ctr Excellence Metab Associated Fatty Liver Dis, Kaohsiung 804, Taiwan
[10] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Dept Internal Med,Hepatobiliary Div, Kaohsiung 807, Taiwan
[11] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung 833, Taiwan
来源:
关键词:
direct-acting antiviral;
viral hepatitis;
hepatitis C;
primary care;
referral model;
screening;
elimination;
VIRUS-INFECTION;
ELIMINATION;
CARE;
D O I:
10.3390/v15040827
中图分类号:
Q93 [微生物学];
学科分类号:
071005 ;
100705 ;
摘要:
Community-based screening for the hepatitis C virus (HCV) decreased during the COVID-19 pandemic. We developed a collaborative referral model between a primary clinic (Liouguei District Public Health Center, LDPHC) and a tertiary referral center to increase HCV screening and treatment uptake in a mountainous region of Taiwan. Once-in-a-lifetime hepatitis B and C screening services established by the Taiwan National Health Insurance were performed at LDPHC. Antibody-to-HCV (anti-HCV)-seropositive patients received scheduled referrals and took a shuttle bus to E-Da hospital for HCV RNA testing on their first visit. Direct-acting antiviral agents (DAAs) were prescribed for HCV-viremic patients on their second visit. From October 2020 to September 2022, of 3835 residents eligible for HCV screening in Liouguei District, 1879 (49%) received anti-HCV testing at LDPHC. The overall HCV screening coverage rate increased from 40% before referral to 69.4% after referral. Of the 79 anti-HCV-seropositive patients, 70 (88.6%) were successfully referred. Of the 38 HCV-viremic patients, 35 (92.1%) received DAA therapy, and 32 (91.4%) achieved sustained virological response. The collaborative referral model demonstrates a good model for HCV screening and access to care and treatment in a Taiwan mountainous region, even during the COVID-19 pandemic. Sustained referral is possible using this routine referral model.
引用
收藏
页数:10
相关论文